annual CFF:
$149.24M-$245.26M(-62.17%)Summary
- As of today (July 1, 2025), APLS annual cash flow from financing activities is $149.24 million, with the most recent change of -$245.26 million (-62.17%) on December 31, 2024.
- During the last 3 years, APLS annual CFF has fallen by -$243.00 million (-61.95%).
- APLS annual CFF is now -78.44% below its all-time high of $692.18 million, reached on December 31, 2020.
Performance
APLS Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$274.00K+$4.27M(+106.85%)Summary
- As of today (July 1, 2025), APLS quarterly cash flow from financing activities is $274.00 thousand, with the most recent change of +$4.27 million (+106.85%) on March 31, 2025.
- Over the past year, APLS quarterly CFF has dropped by -$107.94 million (-99.75%).
- APLS quarterly CFF is now -99.93% below its all-time high of $403.27 million, reached on March 31, 2020.
Performance
APLS quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$41.30M-$107.94M(-72.32%)Summary
- As of today (July 1, 2025), APLS TTM cash flow from financing activities is $41.30 million, with the most recent change of -$107.94 million (-72.32%) on March 31, 2025.
- Over the past year, APLS TTM CFF has dropped by -$70.30 million (-62.99%).
- APLS TTM CFF is now -95.33% below its all-time high of $884.09 million, reached on June 30, 2020.
Performance
APLS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
APLS Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -62.2% | -99.8% | -63.0% |
| 3 y3 years | -62.0% | -99.9% | -94.6% |
| 5 y5 years | -61.6% | -99.9% | -95.3% |
APLS Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -62.2% | at low | -99.9% | +101.7% | -94.6% | at low |
| 5 y | 5-year | -78.4% | at low | -99.9% | +101.7% | -95.3% | +208.2% |
| alltime | all time | -78.4% | +1983.9% | -99.9% | +101.7% | -95.3% | +208.2% |
APLS Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $274.00K(-106.8%) | $41.30M(-72.3%) |
| Dec 2024 | $149.24M(-62.2%) | -$4.00M(-257.4%) | $149.24M(-0.1%) |
| Sep 2024 | - | $2.54M(-94.0%) | $149.33M(-2.1%) |
| Jun 2024 | - | $42.49M(-60.7%) | $152.53M(+36.7%) |
| Mar 2024 | - | $108.21M(-2865.4%) | $111.61M(-71.7%) |
| Dec 2023 | $394.50M(+7.9%) | -$3.91M(-168.1%) | $394.50M(+3.1%) |
| Sep 2023 | - | $5.75M(+268.3%) | $382.47M(-1.0%) |
| Jun 2023 | - | $1.56M(-99.6%) | $386.36M(+1.7%) |
| Mar 2023 | - | $391.11M(-2552.7%) | $380.06M(+3.9%) |
| Dec 2022 | $365.66M(-6.8%) | -$15.95M(-265.5%) | $365.66M(-52.2%) |
| Sep 2022 | - | $9.64M(-303.5%) | $765.56M(+1.0%) |
| Jun 2022 | - | -$4.74M(-101.3%) | $758.05M(-1.2%) |
| Mar 2022 | - | $376.70M(-1.9%) | $767.31M(+95.6%) |
| Dec 2021 | $392.24M(-43.3%) | $383.96M(>+9900.0%) | $392.24M(+2587.5%) |
| Sep 2021 | - | $2.12M(-53.2%) | $14.60M(+8.9%) |
| Jun 2021 | - | $4.53M(+177.3%) | $13.40M(-95.4%) |
| Mar 2021 | - | $1.63M(-74.2%) | $290.54M(-58.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $692.18M(+78.1%) | $6.32M(+582.2%) | $692.18M(+0.9%) |
| Sep 2020 | - | $926.00K(-99.7%) | $686.07M(-22.4%) |
| Jun 2020 | - | $281.67M(-30.2%) | $884.09M(+37.4%) |
| Mar 2020 | - | $403.27M(>+9900.0%) | $643.39M(+65.6%) |
| Dec 2019 | $388.54M(+194.6%) | $209.00K(-99.9%) | $388.54M(+0.0%) |
| Sep 2019 | - | $198.95M(+385.7%) | $388.45M(+105.0%) |
| Jun 2019 | - | $40.96M(-72.4%) | $189.46M(-32.4%) |
| Mar 2019 | - | $148.42M(>+9900.0%) | $280.10M(+112.4%) |
| Dec 2018 | $131.90M(-33.2%) | $115.30K(-400.3%) | $131.90M(-57.4%) |
| Sep 2018 | - | -$38.40K(-100.0%) | $309.83M(-5.9%) |
| Jun 2018 | - | $131.60M(>+9900.0%) | $329.20M(+66.6%) |
| Mar 2018 | - | $222.70K(-99.9%) | $197.60M(+0.1%) |
| Dec 2017 | $197.38M(+1228.0%) | $178.04M(+820.8%) | $197.38M(+920.8%) |
| Sep 2017 | - | $19.33M | $19.33M |
| Dec 2016 | $14.86M(-64.0%) | - | - |
| Dec 2015 | $41.24M(+119.0%) | - | - |
| Dec 2014 | $18.83M(+162.9%) | - | - |
| Dec 2013 | $7.16M | - | - |
FAQ
- What is Apellis Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual CFF year-on-year change?
- What is Apellis Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly CFF year-on-year change?
- What is Apellis Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals TTM CFF year-on-year change?
What is Apellis Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of APLS is $149.24M
What is the all time high annual CFF for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual cash flow from financing activities is $692.18M
What is Apellis Pharmaceuticals annual CFF year-on-year change?
Over the past year, APLS annual cash flow from financing activities has changed by -$245.26M (-62.17%)
What is Apellis Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of APLS is $274.00K
What is the all time high quarterly CFF for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly cash flow from financing activities is $403.27M
What is Apellis Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, APLS quarterly cash flow from financing activities has changed by -$107.94M (-99.75%)
What is Apellis Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of APLS is $41.30M
What is the all time high TTM CFF for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high TTM cash flow from financing activities is $884.09M
What is Apellis Pharmaceuticals TTM CFF year-on-year change?
Over the past year, APLS TTM cash flow from financing activities has changed by -$70.30M (-62.99%)